RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,013,329 | +7.1% | 1,308,932 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $9,352,343 | +21.3% | 1,251,987 | +8.3% | 0.00% | 0.0% |
| Q1 2023 | $7,709,032 | -13.8% | 1,155,777 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $8,941,310 | -25.9% | 1,159,703 | +2.3% | 0.00% | -33.3% |
| Q3 2022 | $12,063,000 | +51.0% | 1,133,698 | +15.5% | 0.00% | +50.0% |
| Q2 2022 | $7,988,000 | +29.8% | 981,282 | +14.2% | 0.00% | +100.0% |
| Q1 2022 | $6,154,000 | -59.5% | 859,544 | -3.0% | 0.00% | -50.0% |
| Q4 2021 | $15,177,000 | +163.1% | 885,961 | +253.4% | 0.00% | +100.0% |
| Q3 2021 | $5,768,000 | -34.8% | 250,671 | +3.4% | 0.00% | -50.0% |
| Q2 2021 | $8,846,000 | – | 242,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |